Streetbeat News

Analyst Ratings

BARK

Jefferies analyst Kaumil Gajrawala upgraded BARK (NYSE:BARK) from Hold to Buy and increased the price target from $1.54 to $1.9, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

March 05, 2024 | 10:52 am

MGX

Chardan Capital analyst Geulah Livshits has initiated coverage on Metagenomi (NASDAQ:MGX) with a Buy rating and set a price target of $21.

Portfolio Pulse from Benzinga Newsdesk

March 05, 2024 | 10:40 am

SFIX

Telsey Advisory Group analyst Dana Telsey has reiterated a 'Market Perform' rating on Stitch Fix (NASDAQ:SFIX) and maintained a $4 price target.

Portfolio Pulse from Benzinga Newsdesk

March 05, 2024 | 10:38 am

TDUP

Telsey Advisory Group analyst Dana Telsey has reiterated an Outperform rating on ThredUp (NASDAQ:TDUP) and maintained a $4 price target on the stock.

Portfolio Pulse from Benzinga Newsdesk

March 05, 2024 | 10:36 am

RNA

Chardan Capital analyst Keay Nakae has maintained a Buy rating on Avidity Biosciences (NASDAQ:RNA) and increased the price target from $23 to $33.

Portfolio Pulse from Benzinga Newsdesk

March 05, 2024 | 10:33 am

VEEV

Keybanc analyst Scott Schoenhaus maintains an Overweight rating on Veeva Systems (VEEV) and raises the price target from $232 to $250.

Portfolio Pulse from Benzinga Newsdesk

March 05, 2024 | 10:02 am

TSLA

Gordon Johnson of GLJ Research questions the high valuation of Tesla's energy storage business compared to its electric-vehicle manufacturing downturn. He highlights the discrepancy in valuation multiples between Tesla and global battery leaders like LG Chem, suggesting Tesla's energy segment is overvalued. Johnson also criticizes Tesla's in-house 4680 battery cells as a 'manufacturing disaster.' Tesla's stock experienced a 7% drop, attributed to weakening EV demand and competition, with analysts predicting another quarter of subpar performance.

Portfolio Pulse from Shanthi Rexaline

March 05, 2024 | 9:44 am

BTCUSD

ETHUSD

SOLUSD

Tether co-founder William Quigley predicts Bitcoin (BTC) could surge 350% to $300,000, driven by sentiment and the upcoming halving event. Quigley's forecast is supported by Bitcoin's current momentum, with a more than 50% increase since the year's start, and the introduction of spot ETFs. He also suggests a potential ripple effect on other cryptocurrencies like Ethereum (ETH) and Solana (SOL), as their value is closely tied to Bitcoin's performance.

Portfolio Pulse from Benzinga Neuro

March 05, 2024 | 9:43 am

GS

Sharmin Mossavar-Rahmani, CIO of Goldman Sachs Group's wealth management, advised against investing in China due to unclear policy direction, economic data, and a potential prolonged economic slowdown. Despite China's efforts to support its economy, such as offering computing vouchers to AI startups, Mossavar-Rahmani highlighted concerns about the stability and transparency of China's economic and policy environment. She also questioned the accuracy of China's official economic growth figures and suggested the Chinese real estate sector might not have reached its lowest point yet.

Portfolio Pulse from Benzinga Neuro

March 05, 2024 | 8:13 am

LLY

NVDA

NVO

Jim Cramer, on his CNBC show 'Mad Money', recommended investors to be prepared for a market sell-off, highlighting Nvidia, Eli Lilly, and Novo Nordisk as not overvalued and worth buying on dips. He dismissed sector bubbles, particularly in AI, and endorsed the valuations of these companies despite their high market caps and competition in their respective sectors.

Portfolio Pulse from Benzinga Neuro

March 05, 2024 | 6:33 am